PACCAR Will increase Its Common Quarterly Dividend By Investing.com
BELLEVUE, Wash.--(BUSINESS WIRE)--The PACCAR Inc Board of Administrators at the moment accredited…
Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Ind
Treatment effects sustained through long-term follow-up of beyond 10 years in the…